News All News

A research team led by Christina Woo, professor of chemistry and chemical biology, in collaboration with a team of scientists at pharmaceutical company GSK and Scripps Research Institute, discovered a hidden binding pocket on the protein cereblon. The discovery of the allosteric cereblon binder could uncover a new area of cereblon biology to explore for cancer drugs.

BioMed X and Harvard launched a pilot initiative under BioMed X’s XBridge framework to support structured research collaborations between academic investigators and pharmaceutical industry scientists through sponsored research agreements.

Sam Liss will become the next leader of OTD as the University’s chief technology development officer and associate provost.

A collaborative research team led by Mikhail Lukin, co-director of the Quantum Science and Engineering Initiative and a professor at the Harvard John A. Paulson School of Engineering and Applied Sciences, published research on a new system that addresses the challenge of quantum error correction. QuEra Computing, a startup company spun out of Lukin’s lab, is collaborating with the research team to advance these discoveries.